This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Airlie, J Articles by Young, C A Search for Related Content PubMed PubMed Citation Articles by Airlie, J Articles by Young, C A Pubmed/NCBI databases Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale

G A Baker

S J Smith

C A Young

Liverpool University Department of Neurosciences, Walton Centre for Neurology and Neurosurgery, Liverpool, UK

Objective: To develop a scale to measure self-efficacy in neurologically impaired patients with multiple sclerosis and to assess the scale' s psychometric properties.

Design: Cross-sectional questionnaire study in a clinical setting, the retest questionnaire returned by mail after completion at home.

Setting: Regional multiple sclerosis (MS) outpatient clinic or the Clinical Trials Unit (CTU) at a large neuroscience centre in the UK.

Subjects: One hundred persons with MS attending the Walton Centre for Neurology and Neurosurgery and Clatterbridge Hospital, Wirral, as outpatients.

Methods: Cognitively impaired patients were excluded at an initial clinic assessment. Patients were asked to provide demographic data and complete the self-efficacy scale along with the following validated scales: Hospital Anxiety and Depression Scale, Rosenberg Self-Esteem Scale, Impact, Stigma and Mastery and Rankin Scales. The Rankin Scale and Barthel Index were also assessed by the physician.

Results: A new 11-item self-efficacy scale was constructed consisting of two domains of control and personal agency. The validity of the scale was confirmed using Cronbach' s alpha analysis of internal consistency ( = 0.81). The test–retest reliability of the scale over two weeks was acceptable with an intraclass correlation coefficient of 0.79. Construct validity was investigated using Pearson' s product moment correlation coefficient resulting in significant correlations with depression (r = –0.52) anxiety (r = –0.50) and mastery (r = 0.73). Multiple regression analysis demonstrated that these factors accounted for 70% of the variance of scores on the self-efficacy scale, with scores on mastery, anxiety and perceived disability being independently significant.

Conclusion: Assessment of the psychometric properties of this new selfefficacy scale suggest that it possesses good validity and reliability in patients with multiple sclerosis. Address for correspondence: SJ Smith, Astley Ainslie Hospital, 133 Grange Loan, Edinburgh EH9 2HL, Scotland, UK.

Clinical Rehabilitation, Vol. 15, No. 3, 259-265 (2001)
DOI: 10.1191/026921501668362643


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. S. Wolf, E. A.H. Wilson, D. N. Rapp, K. R. Waite, M. V. Bocchini, T. C. Davis, and R. E. Rudd Literacy and Learning in Health Care Pediatrics, November 1, 2009; 124(Supplement_3): S275 - S281. [Abstract] [Full Text] [PDF]

				A Riazi, A J Thompson, and J C Hobart Self-efficacy predicts self-reported health status in multiple sclerosis Multiple Sclerosis, February 1, 2004; 10(1): 61 - 66. [Abstract] [PDF]